コンパニオンアニマル用医薬品市場：製品タイプ別、適応症別、動物タイプ別、流通チャネル別-2024年～2030年の世界予測

コンパニオンアニマル用医薬品市場規模は、2023年に147億3,000万米ドルと推定され、2024年には161億5,000万米ドルに達し、CAGR 9.71％で2030年には282億1,000万米ドルに達すると予測されています。

コンパニオンアニマル用医薬品は、犬、猫、馬などのペット用医薬品の発見、開発、生産、販売に携わる獣医学の一分野を網羅しています。これらの医薬品は、糖尿病などの慢性疾患から急性の感染症や伝染病まで、幅広い症状の治療や予防を目的としており、コンパニオンアニマルの健康と幸福を増進させる。コンパニオンアニマルが家族にとって不可欠な存在になるにつれ、そのヘルスケアに対する需要が高まっています。動物と人間の間で感染しやすい病気が蔓延していることから、コンパニオンアニマルのヘルスケアはより注意深く行われる必要があります。しかし、新薬の厳しい承認プロセスを通過することは、時間とコストがかかり、医薬品開発の妨げとなります。ブランド薬に代わる費用対効果の高いジェネリック医薬品の調査は、新たな市場セグメントを開拓する可能性があります。動物用製薬会社は、個々の動物の遺伝学に基づいたオーダーメイドの治療計画に進出しており、バイオメトリクスは提供する製品を差別化できます。さらに、さまざまな病気に対する新しいワクチンや生物学的治療法の開発にも多額の投資が行われています。

製品コンパニオンアニマルの一般的および慢性的な痛みを治療する多様な鎮痛剤

薬用飼料添加物は、病気の治療や予防、動物の健康増進のために飼料に混ぜられる物質です。これらの添加物には、ビタミン、アミノ酸、抗生物質、その他コンパニオンアニマルの健康問題を特にターゲットとした様々な薬剤が含まれます。薬用飼料添加物の必要性は、動物の食事から直接薬を取り入れ、定期的な摂取と投薬スケジュールの遵守を確保する必要がある場合に生じる。ワクチンは、コンパニオンアニマルの感染症予防に極めて重要な役割を果たします。ワクチンは病原体を撃退するために免疫反応を刺激することで機能し、動物の年齢、ライフスタイル、特定の病気への地理的な曝露に基づいて投与されることが多いです。

鎮痛薬は、コンパニオンアニマルの痛みを鎮静や麻酔をかけずに和らげるために使用される薬です。一般的に、変形性関節症、術後の疼痛管理、急性の怪我などの慢性疾患に対して処方されます。抗感染症薬は、抗生物質、抗真菌薬、抗ウイルス薬など、コンパニオンアニマルの感染症を治療するために使用される様々な薬剤で構成されています。抗炎症剤は、ペットの炎症や腫れを抑えるために広く使用されており、皮膚炎や消化器疾患などの症状や術後のケアに欠かせないです。寄生虫駆除剤は、ノミ、マダニ、ダニ、回虫などのコンパニオンアニマルの寄生虫を駆除するために使用される薬剤です。これらの製品の需要は、寄生虫が最も活発に活動する暖かい季節にピークを迎えるのが一般的です。

適応症コンパニオンアニマルの抗菌薬耐性および感染症に対する先端医薬品の開発への注目の高まり

コンパニオンアニマルの行動障害は、不安、抑うつ、強迫行為などの状態から、攻撃性や分離不安などの深刻な症状まで、多岐にわたります。ペットの皮膚疾患は一般的で、アレルギー、感染症、寄生虫が原因となります。皮膚感染症には、症状を素早く緩和し、全身への影響を最小限に抑えて根本的な原因を治療する医薬品が必要です。外用薬、シャンプー、そして経口抗ヒスタミン薬、ステロイド、免疫調整薬などの全身治療薬が使用されます。細菌、ウイルス、真菌、または寄生虫によって引き起こされるコンパニオンアニマルの感染症には、抗生物質、抗真菌薬、抗ウイルス薬、寄生虫特異的な薬剤など、非常に効果的で幅広い活性スペクトルを持つ治療法が必要です。ペットの変形性関節症や関節損傷などの整形外科的疾患では、疼痛と炎症を管理し、関節機能を維持できる治療が必要であり、非ステロイド性抗炎症薬（NSAIDs）や多硫酸化グリコサミノグリカンなどの新しい治療薬を用いた治療がほとんどです。コンパニオンアニマルの疼痛管理は、急性および慢性疾患のいずれにおいても重要です。鎮痛薬の必要性は即座に緩和をもたらすことであり、大きな副作用がないことが理想です。これにはオピオイド鎮痛薬、非ステロイド性抗炎症薬、ガバペンチンなどの補助療法が含まれます。

動物の種類：コンパニオンアニマルとしての犬の飼育増加と治療費の増加

猫は、猫免疫不全ウイルス（FIV）、猫白血病ウイルス（FeLV）、関節炎、歯科疾患などの特定の疾患にかかりやすいため、それぞれに合った医薬品が必要となります。犬用医薬品市場は、多様な犬種とそれに関連する健康ニーズにより、広範囲に及んでいます。この分野では、ワクチン、心臓病予防薬、ノミ・マダニ治療薬、抗炎症薬、行動健康薬など、幅広い製品を扱っています。馬用医薬品市場は、馬特有の生理的・体格的特徴に対応した製品に重点を置いています。ワクチン、生殖健康治療薬、抗炎症薬や疼痛管理薬を含む筋骨格系治療薬に対する需要が大きいです。一般的に、犬はすべての健康カテゴリーにおいて最も多様な医薬品ニーズを持っており、最も幅広い製品とメーカーに支えられています。ネコの医薬品市場はよりニッチだが、ネコの慢性疾患の微妙な徴候が認識されるようになり、特殊な治療法が開発されるなど、成長しています。馬用医薬品市場は、流通量は少ないが、必要量が多く、多くの治療法がオーダーメイドであるため、単価は高いです。

流通チャネル：オンライン・チャネルによるコンパニオンアニマル用医薬品の入手のしやすさと利便性の向上

オンライン薬局は、ペットの飼い主が薬を購入するのに便利なプラットフォームを提供します。これらのチャネルは、24時間365日利用可能で、競争力のある価格設定と宅配サービスが支持されています。オンライン薬局は、利便性を優先する消費者や、実店舗や動物病院にすぐに行けない消費者にとって特に魅力的です。小売薬局は、コンパニオンアニマル用医薬品にとってもう一つの重要な販売拠点です。その場で専門家のアドバイスが受けられ、すぐに製品を入手することができます。対面でのやり取りを好む顧客や緊急の薬を求める顧客は、小売薬局を選ぶことが多いです。動物病院は、獣医師による個人的で専門的なサービスにより、ペットの飼い主にとって信頼できる医薬品の供給源であり続けています。診療所では、その場で薬を調剤することで、診察後の処方箋記入の利便性と即時性、そして専門的な指導の保証を提供しています。これらのクリニックは通常、メーカーから直接、または獣医学に特化した代理店を通じて製品を調達しています。動物病院は包括的な医療を提供し、専門薬や緊急薬など、より広範なコンパニオンアニマル用医薬品を在庫しています。これらの施設は、高度な治療を必要とする複雑な健康問題や、様々な医薬品への即時の現場アクセスが好まれます。大規模な動物病院チェーンは、重要な医薬品の安定供給を確保するため、メーカーと提携していることが多いです。

地域別インサイト

南北南北アメリカでは、ペット人口の多さと飼い主の高度獣医療志向を反映して、コンパニオンアニマル用医薬品の使用率が高いです。南北アメリカは、多くの大手製薬会社がこの地域に進出しており、強固な生産能力を示しています。APAC地域ではコンパニオンアニマル（伴侶動物）の飼育が増加しており、動物用医薬品の需要を促進しています。しかし、使用パターンは多様化しており、動物の健康に対する認識と支出がまだ発展途上にある新興諸国に比べ、日本、オーストラリア、韓国などの国々では高い成長を示しています。中国やインドなどの国々は、生産コストの低下と品質基準の向上により、重要な製造拠点として台頭してきています。また、特にアジアの製薬産業が盛んな国々では、研究開発への投資も顕著です。欧州では、規制基準が厳しく、安全性と有効性が重視されることを特徴とするコンパニオンアニマル用医薬品の市場が確立されています。予防薬と並んで慢性疾患管理薬の需要が高いことが特徴です。欧州地域には、欧州医薬品庁（EMA）の規制に準拠した高品質な基準に焦点を当てた、確立された生産施設があります。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、コンパニオンアニマル用医薬品市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、コンパニオンアニマル用医薬品市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.コンパニオンアニマル用医薬品市場の市場規模および予測は？

2.コンパニオンアニマル用医薬品市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.コンパニオンアニマル用医薬品市場の技術動向と規制枠組みは？

4.コンパニオンアニマル用医薬品市場における主要ベンダーの市場シェアは？

5.コンパニオンアニマル用医薬品市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 人獣共通感染症および慢性疾患の蔓延の増加
    • ペットの数の増加と衛生に関する意識
    • 動物のヘルスケアに関する人々の意識と支出の増加
  • 抑制要因
    • ペット動物用医薬品 APIに関連するいくつかのリスク要因
  • 機会
    • ペット用新薬・ワクチンの開発
    • 新興経済諸国における市場プレーヤーの出現と戦略的連携
  • 課題
    • 医薬品の承認に関する厳格な規制
• 市場セグメンテーション分析
  • 製品：ペットの一般的な痛みや慢性的な痛みを治療するための多様な鎮痛剤
  • 適応症：ペットの抗菌薬耐性および感染症に対する先進的な医薬品の開発への注目が高まる
  • 動物の種類：ペットとしての犬の導入が増加し、その治療費も増加している
  • 配信チャネル：オンラインチャネルを通じてコンパニオンアニマル用医薬品を入手する際のアクセス性と利便性の向上
• 市場動向分析
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析
• 顧客のカスタマイズ

第6章 コンパニオンアニマル用医薬品市場：製品別

• 鎮痛剤
• 抗感染薬
• 抗炎症
• 医薬品添加飼料添加物
• 寄生虫駆除剤
• ワクチン

第7章 コンパニオンアニマル用医薬品市場適応症別

• 行動障害
• 皮膚疾患
• 感染症
• 整形外科疾患
• 痛み

第8章 コンパニオンアニマル用医薬品市場動物の種類別

• 猫
• 犬
• 馬

第9章 コンパニオンアニマル用医薬品市場：流通チャネル別

• オンライン薬局
• 小売薬局
• 獣医クリニック
• 動物病院

第10章 南北アメリカのコンパニオンアニマル用医薬品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のコンパニオンアニマル用医薬品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのコンパニオンアニマル用医薬品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • ゾエティス、米国獣医市場でFDA承認医薬品 2種類を正式に発売
  • 治療薬開発企業がペットの健康に注力
  • ゾエティス、家畜およびペット動物向け製品の大手プロバイダーであるジュロックスの買収完了を発表

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. COMPANION ANIMAL PHARMACEUTICALS MARKET RESEARCH PROCESS
• FIGURE 2. COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. COMPANION ANIMAL PHARMACEUTICALS MARKET DYNAMICS
• FIGURE 7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. COMPANION ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. COMPANION ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COMPANION ANIMAL PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANALGESICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY BEHAVIORAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY BEHAVIORAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PAIN, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PAIN, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY CATS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY CATS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DOGS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DOGS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY HORSES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY HORSES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 52. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 53. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 54. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 55. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 56. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 57. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 58. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 59. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 60. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 61. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 62. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 63. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 64. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 65. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 66. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 67. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 68. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 69. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 70. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 71. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 72. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 73. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 74. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 75. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 76. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 77. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 78. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 79. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 80. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 81. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 82. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 83. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 84. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 85. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 86. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 87. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 88. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 89. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 90. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 91. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 92. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 93. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 94. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 95. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 96. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 97. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 98. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 99. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 100. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 101. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 102. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 104. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 106. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 108. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 110. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 112. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 113. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 114. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 115. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 116. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 117. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 118. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 119. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 120. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 121. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 122. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 123. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 124. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 125. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 126. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 127. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 128. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 129. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 130. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 131. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 132. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 133. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 134. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 135. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 136. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 137. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 138. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 139. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 140. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 141. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 142. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 143. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 144. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 145. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 146. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 147. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 148. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 149. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 150. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 151. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 152. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 153. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 154. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 155. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 156. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 157. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 158. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 159. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 160. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 161. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 162. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 163. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 164. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 165. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 166. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 167. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 168. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 169. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 170. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 171. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 172. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 173. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 174. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 175. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 176. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 177. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 178. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 179. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 180. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 181. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 182. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 183. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 184. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 185. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 186. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 187. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 188. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 189. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 190. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 191. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 192. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 193. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 194. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 195. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 196. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 197. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 198. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 199. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 200. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 201. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 202. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 203. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 204. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 205. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 206. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 207. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 208. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 213. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 214. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 215. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 216. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 217. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 218. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 219. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 220. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 221. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 222. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 223. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 224. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 225. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 226. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 227. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 228. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 229. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 230. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 231. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 232. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 233. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 234. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 235. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 236. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 237. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 238. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 239. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 240. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 241. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 242. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 243. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 244. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 245. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 246. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 247. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 248. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 249. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 250. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 251. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 252. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 253. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 254. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 255. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 256. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 257. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 258. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 259. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 260. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 261. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 262. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 263. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 264. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 265. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 266. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 267. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 268. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 269. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 270. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 271. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 272. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 273. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 274. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 275. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 276. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 277. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 278. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 279. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 280. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 281. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 282. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 283. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 284. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 285. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 286. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 287. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 288. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 289. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 290. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 291. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 292. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 293. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 294. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 295. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 296. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 297. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 298. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 299. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 300. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 301. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 302. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 303. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
• TABLE 304. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
• TABLE 305. POLAND COMPANION ANIMAL PHARMACE

[181 Pages Report] The Companion Animal Pharmaceuticals Market size was estimated at USD 14.73 billion in 2023 and expected to reach USD 16.15 billion in 2024, at a CAGR 9.71% to reach USD 28.21 billion by 2030.

Companion animal pharmaceuticals encompasses the branch of veterinary medicine that is involved in the discovery, development, production, and marketing of drugs for pets, such as dogs, cats, and horses. These pharmaceuticals are designed to treat or prevent a wide range of conditions, from chronic diseases such as diabetes to acute infections or infestations, enhancing the health and well-being of companion animals. As companion animals become more integral to families, there is a rise in the demand for their healthcare. The prevalence of diseases transferable between animals and humans prompts more vigilant healthcare practices for companion animals. However, navigating through rigorous approval processes for new drugs can be time-consuming and costly, impeding the process of drug and pharmaceutical development. Research into cost-effective generic alternatives to branded medication can open up new market segments. Veterinary pharmaceutical companies are expanding into tailored treatment plans based on individual animal genetics, and biometrics can differentiate offerings. Moreover, there have been significant investments in the development of new vaccines and biologic treatments for various diseases.

Product: Diverse range of analgesics to treat general and chronic pain in companion animals

Medicated feed additives are substances mixed with animal feed to treat or prevent diseases and improve animal health. These additives include vitamins, amino acids, antibiotics, and various other drugs that specifically target health issues in companion animals. The need for medicated feed additives arises when there is a requirement for direct incorporation of medication through the animal's diet, ensuring regular intake and adherence to the medication schedule. Vaccines play a pivotal role in preventing infectious diseases in companion animals. They work by stimulating the immune response to fight off pathogens and are often administered based on an animal's age, lifestyle, and geographic exposure to specific diseases.

Analgesics are medications used to relieve pain in companion animals without causing sedation or anesthesia. They are commonly prescribed for chronic conditions, including osteoarthritis, post-surgical pain management, or acute injuries. Anti-infectives comprise a range of drugs, including antibiotics, antifungals, and antivirals, that are used to treat infections in companion animals. Anti-inflammatory drugs are widely used to reduce inflammation and swelling in pets, and they are crucial for conditions such as dermatitis and gastrointestinal diseases and for post-operative care. Parasiticides are agents used to eliminate parasites from companion animals such as fleas, ticks, mites, and worms. Demand for these products typically peaks during warmer months when parasites are most active.

Indication: Rising focus on developing advanced pharmaceuticals for antimicrobial resistance and infectious diseases in companion animals

Behavioral disorders in companion animals can range from conditions such as anxiety, depression, and compulsive behavior to more severe manifestations such as aggression or separation anxiety. Skin conditions in pets are common and can be due to allergies, infections, or parasites. Skin infections require pharmaceutical products that offer quick relief of symptoms and target underlying causes with minimal systemic effects. Topicals, shampoos, and systemic treatments, including oral antihistamines, steroids, and immune-modulating drugs, are used. Infectious diseases in companion animals caused by bacteria, viruses, fungi, or parasites require treatments that are highly effective and have a broad spectrum of activity, which includes antibiotics, antifungals, antivirals, and parasite-specific medications. Orthopedic ailments, including osteoarthritis and joint injuries in pets, necessitate treatments that can manage pain and inflammation and preserve joint function and mostly require treatments with non-steroidal anti-inflammatory drugs (NSAIDs) and newer therapies such as polysulfated glycosaminoglycans. Pain management in companion animals is critical for both acute and chronic conditions. The need for pain medications is to provide immediate relief, ideally without significant side effects. This includes opioid analgesics, NSAIDs, and adjunctive therapies, including gabapentin.

Animal Type: Increased adoption of dogs as companion animals and rising expenditure on their treatments

Cats are prone to certain conditions such as feline immunodeficiency virus (FIV), feline leukemia virus (FeLV), arthritis, and dental diseases, necessitating tailored pharmaceutical solutions. The canine pharmaceutical market is extensive due to the variety of breeds and their associated health needs. This segment covers a broad spectrum of products, including vaccines, heartworm prevention, flea and tick treatments, anti-inflammatories, and behavioral health medications. The equine pharmaceutical market focuses on products that address the unique physiological and size considerations of horses. There is a significant demand for vaccines, reproductive health treatments, and musculoskeletal system medications, including anti-inflammatories and pain management drugs. Dogs generally have the most diversified need for pharmaceuticals across all health categories, supported by the largest range of products and manufacturers. The feline pharmaceutical market is more niche but is growing, with an increasing recognition of the subtler signs of chronic conditions in cats and the development of specialized treatments. The equine market, while smaller in volume, commands higher unit prices due to the larger dosages required and the bespoke nature of many treatments.

Distribution Channel: Enhanced accessibility and convenience of attaining companion animal pharmaceuticals through online channels

Online pharmacies provide a convenient platform for pet owners to purchase medications. These channels are favored for their 24/7 availability, competitive pricing, and home delivery services. Online pharmacies are particularly appealing to consumers who prioritize convenience and those who may not have immediate access to physical stores or veterinary services. Retail pharmacies are another vital point of sale for companion animal pharmaceuticals. They offer on-spot expert advice and immediate product availability. Customers who prefer in-person interaction or are seeking urgent medications often choose retail pharmacies. Veterinary clinics remain a trusted source of pharmaceuticals for pet owners, largely due to the personal and professional service provided by veterinarians. By dispensing medications on-site, clinics offer a level of convenience and immediacy for prescription fulfillment after consultation, as well as the assurance of professional guidance. These clinics typically source their products directly from manufacturers or through veterinary-focused distributors. Veterinary hospitals provide comprehensive medical care and stock a more extensive range of companion animal pharmaceuticals, including specialized and emergency medications. These establishments are preferred for complex health issues requiring advanced treatment and immediate onsite access to a variety of drugs. Large animal hospital chains often partner with manufacturers to ensure a steady supply of critical medications.

Regional Insights

In the Americas, there is a high usage rate of companion animal pharmaceuticals, reflecting the substantial pet population and pet owners' inclination towards advanced veterinary care. The Americas demonstrates robust production capabilities, with many major pharmaceutical companies operating within the region. The APAC region is witnessing a growing adoption of companion animals, which is fuelling the demand for animal health products. However, the usage pattern is diversified with higher growth in countries such as Japan, Australia, and South Korea, compared to emerging markets where awareness and expenditure on animal health are still developing. Countries such as China and India are emerging as significant manufacturing hubs due to lower production costs and improving quality standards. There is also a notable investment in R&D, particularly in countries with a strong pharmaceutical industry in Asia. In Europe, there is a well-established market for companion animal pharmaceuticals characterized by stringent regulatory standards and a focus on safety and efficacy. The usage is marked by a high demand for chronic disease management products alongside preventive medications. The European region has well-established production facilities with a focus on high-quality standards compliant with the European Medicines Agency (EMA) regulations.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Companion Animal Pharmaceuticals Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Companion Animal Pharmaceuticals Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Companion Animal Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Alivira Animal Health Limited, Ashish Life Science Pvt. Ltd., Boehringer Ingelheim International GmbH, Century Pharmaceuticals Ltd., Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Eco Animal Health Group PLC, Elanco Animal Health Incorporated, Endovac Animal Health, LLC, Hester Biosciences Limited, Hipra Laboratories, S.A., Indian Immunologicals Ltd., Kyoritsu Seiyaku Corporation, Lutim Pharma Pvt. Ltd., Meiji Group, Merck & Co. Inc., Neogen Corporation, Norbrook Laboratories Ltd., Orion Corporation, Phibro Animal Health Corporation, SkyEc Pharmaceuticals Private Limited, Stanex Drugs and Chemicals Pvt Ltd., Tianjin Ringpu Biotechnology Co., Ltd., Veko Care, Vetbiolix, Vetneeds Group, Virbac S.A., Zoetis Inc., and Zydus Animal Health.

Market Segmentation & Coverage

This research report categorizes the Companion Animal Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Analgesics
  • Anti-infectives
  • Anti-inflammatory
  • Medicated Feed Additives
  • Parasiticides
  • Vaccines

• Indication
  • Behavioral Disorders
  • Dermatologic Diseases
  • Infectious Diseases
  • Orthopedic Diseases
  • Pain

• Animal Type
  • Cats
  • Dogs
  • Horses

• Distribution Channel
  • Online Pharmacies
  • Retail Pharmacies
  • Veterinary Clinics
  • Veterinary Hospitals

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Companion Animal Pharmaceuticals Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Companion Animal Pharmaceuticals Market?

3. What are the technology trends and regulatory frameworks in the Companion Animal Pharmaceuticals Market?

4. What is the market share of the leading vendors in the Companion Animal Pharmaceuticals Market?

5. Which modes and strategic moves are suitable for entering the Companion Animal Pharmaceuticals Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Prevalence of Zoonotic and Chronic Diseases
    • 5.1.1.2. Rising Number of Companion Animals and Awareness About their Hygiene
    • 5.1.1.3. Increasing Awareness and Expenditure Among People Regarding Animal Healthcare
  • 5.1.2. Restraints
    • 5.1.2.1. Several Risk Factors Associated with Companion Animal Health APIs
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of New Drugs and Vaccines for Companion Animal
    • 5.1.3.2. Strategic Collaborations Along with Emergence of Market Players Across the Developing Economies
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent Regulations Associated with the Approval for Drugs
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Diverse range of analgesics to treat general and chronic pain in companion animals
  • 5.2.2. Indication: Rising focus on developing advanced pharmaceuticals for antimicrobial resistance and infectious diseases in companion animals
  • 5.2.3. Animal Type: Increased adoption of dogs as companion animals and rising expenditure on their treatments
  • 5.2.4. Distribution Channel: Enhanced accessibility and convenience of attaining companion animal pharmaceuticals through online channels
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework Analysis
• 5.9. Client Customization

6. Companion Animal Pharmaceuticals Market, by Product

• 6.1. Introduction
• 6.2. Analgesics
• 6.3. Anti-infectives
• 6.4. Anti-inflammatory
• 6.5. Medicated Feed Additives
• 6.6. Parasiticides
• 6.7. Vaccines

7. Companion Animal Pharmaceuticals Market, by Indication

• 7.1. Introduction
• 7.2. Behavioral Disorders
• 7.3. Dermatologic Diseases
• 7.4. Infectious Diseases
• 7.5. Orthopedic Diseases
• 7.6. Pain

8. Companion Animal Pharmaceuticals Market, by Animal Type

• 8.1. Introduction
• 8.2. Cats
• 8.3. Dogs
• 8.4. Horses

9. Companion Animal Pharmaceuticals Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Online Pharmacies
• 9.3. Retail Pharmacies
• 9.4. Veterinary Clinics
• 9.5. Veterinary Hospitals

10. Americas Companion Animal Pharmaceuticals Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Companion Animal Pharmaceuticals Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Companion Animal Pharmaceuticals Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Zoetis Officially Launches 2 FDA Approved Drugs in the US Veterinary Market
  • 13.3.2. Therapeutics Developer Turns Its Focus To Companion Animal Health
  • 13.3.3. Zoetis Announces the Completion of its Acquisition of Jurox, a Leading Provider of Livestock and Companion Animal Products

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio